Guidance for non-hospital-based Inpatient, residential, and outpatient treatment settings where Individuals under the movement restriction for COVID-19 have been admitted or have visited. Updated 6/5/20.

OASAS certified or authorized providers should submit a self-attestation for permission to utilize Telepractice during the COVID-19 emergency. Issued 3/20/20. Updated 5/12/20.

NYS DOH guidance on discontinuing isolation for patients with COVID-19 who are hospitalized or in nursing homes, adult care homes, or other congregate settings with vulnerable...

Guidance form NYS DOH on the use of cloth masks and coverings. Issued April 8, 2020.

NYS DOH guidance for understanding the risks to contacts of suspected or confirmed cases of COVID-19. Issued 4/3/20.

Health advisory from the NYS Department of Health to all providers and practitioners outlining options for when personal protective equipment (PPE) is in short supply or...

Drug Enforcement Administration guidance allowing for more flexibility for practitioners to prescribe buprenorphine to new and existing patients with OUD via telephone during the nationwide public health emergency...

NYS Department of Health: protocols for essential personnel to return to work following COVID-19 exposure or infection. Updated 03/28/20.

OASAS guidance on the Drug Enforcement Administration's recent action of approving buprenorphine induction via telephone amid the COVID-19 pandemic.

NYS DOH Health Advisory to behavioral health providers regarding release from home isolation amid the COVID-19 pandemic.